Simultaneous estimation of olmesartan medoxomil and hydrochlorothiazide by spectrophotometry in tablet formulation.

Raman N Kachave, Rajendra N Bhadane, Rajendra Wagh, Deepti. Jain

Research output: Contribution to journalArticleScientificpeer-review

Abstract

Two precise, accurate, sensitive spectrophotometric methods was developed and validated for the simultaneous estn. of olmesartan medoxomil (OLM) and hydrochlorothiazide (HCT) in tablet formulation. In dual wavelength method absorbance difference at 254.8 nm and 284 nm were considered for estn. of OLM while HCT was estd. as single component at 322 nm. In simultaneous equation method estn. of OLM and HCT was carried out at 249 nm and 273.5 nm resp. Regression anal. of beers plots showed good correlation in concn. range of 0-25 μg/mL for OLM and HCT resp. Accuracy was detd. by recovery studies from tablet dosages form and ranges from 98-101%. Precision of method was find out as repeatability, day to day and analyst to analyst variation and shows the values within limit (R.S.D. ≤ 2). [on SciFinder(R)]
Original languageEnglish
Pages (from-to)1047-1049
Number of pages3
JournalResearch Journal of Pharmacy and Technology
Volume3
Issue number4
Publication statusPublished - 2010
MoE publication typeA1 Journal article-refereed

Keywords

  • olmesartan hydrochlorothiazide spectroscopy

Fingerprint Dive into the research topics of 'Simultaneous estimation of olmesartan medoxomil and hydrochlorothiazide by spectrophotometry in tablet formulation.'. Together they form a unique fingerprint.

Cite this